We are pleased that CMS recognizes the therapeutic worth of proton therapy.

AMS happy with CMS’ upsurge in 2012 payment price for proton therapy AMERICAN SHARED HOSPITAL SERVICES , a leading provider of turnkey technology solutions for advanced radiosurgical and radiation therapy services, said today that the latest announcement by the Centers for Medicare & Medicade Solutions of a 15 percent increase in the payment rate of proton therapy for hospital based centers from 2012 strengthens the financial case for the proton centers now in development by the Company. We are pleased that CMS recognizes the therapeutic worth of proton therapy, right now widely regarded as the perfect radiation treatment for a growing variety of cancers. This payment boost will facilitate the development of much-needed proton therapy centers throughout the national country, stated AMS Chief and Chairman Executive Officer Ernest A dapoxetine .

Related StoriesSurgical startup seeks funding to build virtual reality training libraryReducing medical center readmissions through Transitional Care: an interview with Rani KhetarpalUsing integrated molecular pathology to control incidental pancreatic cysts: an interview with Dr Ananya Das Under the conditions of the agreement, ApolloMed and AMVI will partner to supply ACO patients with top quality care focused on attaining better outcomes at lower costs. ‘We welcome AMVI to our ACO network,’ mentioned Warren Hosseinion, M.D., Chief Executive Officer of Apollo Medical Holdings, Inc. ‘ApolloMed ACO can be embarking on an effort to transform the product quality, satisfaction and efficiency of patient care, that will have a positive influence on the community's health.’ ‘Participating in ApolloMed ACO will allow AMVI to remain at the forefront of healthcare reform,’ mentioned Co Pham, M.D., Chief Executive Officer and President of AMVI.

You Might Also Like